pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    MVCCOV-1901
    Coronavirus Disease 2019 (COVID-19) Medigen Vaccine Biologics Corp
  • Phase 2
    MVRT-3011
    Recurrent Head And Neck Squamous Cell Carcinoma Immvira Co Ltd
  • Phase 2
    MVX-220
    Angelman Syndrome Mavrix Bio LLC
  • Phase 2
← prev
page 19 of 50
next →
131
Pain89
Neurology1
MWTx-01
Polycythemia Vera
$IRON Disc Medicine, Inc.
  • Phase 2
    MZ-1866
    Unspecified Genetic Disorders Mahzi Therapeutics Inc
  • Phase 2
    MaaT-013
    Graft Versus Host Disease (GVHD) MaaT Pharma SA
  • Phase 2
    MesenCure
    Acute Respiratory Distress Syndrome Bonus BioGroup Ltd
  • Phase 2
    MesoCancerVac
    MesoPher
    Malignant Mesothelioma Amphera BV
  • Phase 2
    Motrem
    Septic Shock Inotrem SA
  • Phase 2
    Mydicar
    Mydicar
    Systolic Heart Failure (HFrEF) Sardocor Corp
  • Phase 2
    N-acetyl cysteine amide
    Retinitis Pigmentosa (Retinitis) Nacuity Pharmaceuticals Inc
  • Phase 2
    NA-704
    Amyotrophic Lateral Sclerosis Biomed Industries Inc
  • Phase 2
    NA-931
    Obesity Biomed Industries Inc
  • Phase 2
    NB-001
    DiGeorge Syndrome Nobias Therapeutics Inc
  • Phase 2
    NB-003
    Gastrointestinal Stromal Tumor (GIST) NewBay Medical Technology Co Ltd
  • Phase 2
    NBM-BMX
    Metastatic Uveal Melanoma Novelwise Pharmaceutical Corp
  • Phase 2
    NC-410
    Cervical Cancer$NXTC NextCure, Inc.
  • Phase 2
    NCS-01
    Acute Ischemic Stroke NC Medical Research Inc
  • Phase 2
    ND-10 ER
    Myopia Theialife Sciences Pvt Ltd
  • Phase 2
    NEO-100
    Recurrent Glioblastoma Multiforme (GBM)$NTHI NEONC TECHNOLOGIES HOLDINGS, INC.
  • Phase 2
    NEO-212
    Astrocytoma$NTHI NEONC TECHNOLOGIES HOLDINGS, INC.
  • Phase 2
    NG-350A
    Epithelial Tumor Akamis Bio Ltd
  • Phase 2
    NGGT-002
    Phenylketonuria (PKU) Next Generation Gene Therapeutics Inc
  • Phase 2
    NOUS-209
    Gastric Cancer Nouscom AG
  • Phase 2
    NP-213
    Novexatin
    Onychomycosis (Tinea Unguium) Novabiotics Ltd
  • Phase 2
    NRT-023
    Post Partum Depression (Maternal Depression / Postnatal D… Nanjing Noratech Pharmaceutical Inc
  • Phase 2
    NS-050
    Duchenne Muscular Dystrophy NS Pharma Inc
  • Phase 2
    NS-229
    Eosinophilic Granulomatosis with Polyangiitis (Churg-Stra… Nippon Shinyaku Co Ltd
  • Phase 2
    NT-101
    Wet (Neovascular / Exudative) Macular Degeneration NexThera Co Ltd
  • Phase 2
    NT-219
    Metastatic Colorectal Cancer$PPBT PURPLE BIOTECH LTD.